Data Insights
No Filter Selected
Q4 2023 update: private equity deals in pharmaceutical in Europe
In the European pharmaceutical industry, there were 21 private equity deals announced in Q4 2023, worth a total value of...
Q4 2023 update: M&A activity in pharmaceutical in North America
In the North American pharmaceutical industry, there were 228 M&A deals announced in Q4 2023, worth a total value of...
Q4 2023 update: private equity deals in pharmaceutical in the UK
In the British pharmaceutical industry, there were 6 private equity deals announced in Q4 2023, worth a total value of...
Q4 2023 update: M&A activity in pharmaceutical in Asia-Pacific
In the Asia-Pacific pharmaceutical industry, there were 104 M&A deals announced in Q4 2023, worth a total value of $16.1bn,...
Q4 2023 update: private equity deals in pharmaceutical in China
In the Chinese pharmaceutical industry, there were 2 private equity deals announced in Q4 2023, worth a total value of...
How did Private equity deals perform in pharmaceutical in Q4 2023?
In the global pharmaceutical industry, there were 66 private equity deals announced in Q4 2023, worth a total value of...
Q4 2023 update: M&A activity in pharmaceutical in Europe
In the European pharmaceutical industry, there were 87 M&A deals announced in Q4 2023, worth a total value of $9.2bn,...
Q4 2023 update: M&A activity in pharmaceutical in Germany
In the German pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $45m,...
Q4 2023 update: M&A activity in pharmaceutical in the UK
In the British pharmaceutical industry, there were 33 M&A deals announced in Q4 2023, worth a total value of $779.7m,...
Q4 2023 update: private equity deals in pharmaceutical in North America
In the North American pharmaceutical industry, there were 34 private equity deals announced in Q4 2023, worth a total value...
Q4 2023 update: M&A activity in pharmaceutical in Italy
In the Italian pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total value of $6.9bn,...
Q4 2023 update: M&A activity in pharmaceutical in Japan
In the Japanese pharmaceutical industry, there were 19 M&A deals announced in Q4 2023, worth a total value of $1.5bn,...
Q4 2023 update: M&A activity in pharmaceutical in South and Central America
In the South and Central America pharmaceutical industry, there were 5 M&A deals announced in Q4 2023, worth a total...
Q4 2023 update: private equity deals in pharmaceutical in the US
In the US pharmaceutical industry, there were 31 private equity deals announced in Q4 2023, worth a total value of...
Q4 2023 update: M&A activity in pharmaceutical in Middle East and Africa
In the Middle East and Africa pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total...
Q4 2023 update: M&A activity in pharmaceutical in Canada
In the Canadian pharmaceutical industry, there were 19 M&A deals announced in Q4 2023, worth a total value of $247m,...
Q4 2023 update: M&A activity in pharmaceutical in India
In the Indian pharmaceutical industry, there were 19 M&A deals announced in Q4 2023, worth a total value of $7.4bn,...
How did M&A perform in pharmaceutical in Q4 2023?
In the global pharmaceutical industry, there were 426 M&A deals announced in Q4 2023, worth a total value of $84.2bn,...
Q4 2023 update: M&A activity in pharmaceutical in France
In the French pharmaceutical industry, there were 6 M&A deals announced in Q4 2023, worth a total value of $7.4bn,...
Q4 2023 update: M&A activity in pharmaceutical in China
In the Chinese pharmaceutical industry, there were 29 M&A deals announced in Q4 2023, worth a total value of $3.5bn,...